Clinical Trials on Primary Molar Pulpotomy in United States

Total 25493 results

OxThera

Completed

Phase 2/3 Oxabact Study

Primary Hyperoxaluria

United States, Germany, Netherlands
National Foundation for Fertility Research
Fertility Laboratories Of Colorado

Terminated

In Vitro Follicle Activation (IVA)

Infertility | Primary Ovarian Insufficiency

United States
University of Texas Southwestern Medical Center
Texas Health Resource

Completed

Influence of Early Menopause on Sympathetic Activation and Cardiovascular Function in Older Women

Menopause | Early Menopause

United States
Center for Human Reproduction

Terminated

Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility (DHEAFert)

Primary Ovarian Insufficiency | Unexplained Infertility

United States
National Cancer Institute (NCI)

Completed

Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
National Cancer Institute (NCI)

Completed

Oxaliplatin in Treating Patients With Liver Cancer

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
M.D. Anderson Cancer Center
Sanofi-Synthelabo

Completed

Gemox as First and Second Line Therapy in Unknown Primary Cancer

Unknown Primary Neoplasms

United States
Dicerna Pharmaceuticals, Inc.

Completed

Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria

Primary Hyperoxaluria

United States, France, Germany, Netherlands, United Kingdom
University of Pittsburgh

Completed

Acceptability of Social Risk Screening

Primary Health Care

United States
University of Cincinnati

Completed

Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts

Primary Renal Allograft

United States
University of Wisconsin, Madison

Completed

Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation

Primary Renal Transplant

United States
City of Hope Medical Center

Active, not recruiting

Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma

HIV Infection | AIDS-related Non-Hodgkin Lymphoma | AIDS-related Plasmablastic Lymphoma | AIDS-related Primary Effusion Lymphoma

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

3-Tesla MRI Response to TACE in HCC (Liver Cancer)

Advanced Adult Primary Liver Cancer | Localized Resectable Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma | Stage A Adult Primary Liver Cancer (BCLC) | Stage B Adult Primary Liver Cancer (BCLC)

United States
University of Colorado, Denver
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

Engaging Practices and Communities in the Development of Interventions to Promote HPV Vaccine Uptake

Primary Prevention

United States
University of Colorado, Denver
Centers for Disease Control and Prevention

Active, not recruiting

Using Boot Camp Translation to Address Rural Disparities in Adolescent Vaccination (RADVax)

Primary Prevention

United States
VA Office of Research and Development

Completed

Improving Patient-centered Care Using an Inventory

Primary Care

United States
Alnylam Pharmaceuticals

Active, not recruiting

A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1 (ILLUMINATE-B)

Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria

United States, France, United Kingdom, Israel, Germany
Rachel Miller

Completed

Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma

Fallopian Tube Carcinoma | Ovarian Carcinoma | Primary Peritoneal Carcinoma

United States
University of Washington
National Cancer Institute (NCI)

Completed

Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant

Advanced Adult Primary Liver Cancer | Localized Resectable Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
Corin

Completed

Accuracy of OPS™ Femoral Neck Resection Study

Primary Total Hip Arthroplasty

United States
National Cancer Institute (NCI)

Completed

Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI); Incyte Corporation; Celldex Therapeutics

Completed

DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission

Fallopian Tube Carcinoma | Ovarian Carcinoma | Primary Peritoneal Carcinoma

United States
University of Tennessee

Completed

Screening for Therapy and Empowering Parents: A Pilot Study

Primary Health Care

United States
Glen Taksler
National Institute on Aging (NIA)

Terminated

Individualizing Disease Prevention for Middle-Aged Adults

Primary Health Care

United States
Johns Hopkins University
Gordon and Betty Moore Foundation; emocha Mobile Health, Inc.; Maryland Institute...

Completed

Salud al Día: Engaging Latino Parents in Pediatric Primary Care

Primary Health Care

United States
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Recruiting

Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function (PHYOX8)

Primary Hyperoxaluria Type 3 | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1 | Primary Hyperoxaluria

United States, Canada, Lebanon, Turkey, United Kingdom, Germany, Italy, Japan, Poland, Spain, United Arab Emirates
National Cancer Institute (NCI)

Terminated

AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
National Cancer Institute (NCI)

Completed

IMC-A12 in Treating Patients With Advanced Liver Cancer

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
National Cancer Institute (NCI)

Completed

Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
National Cancer Institute (NCI)

Completed

Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Stage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity Cancer | Stage IIIA Ovarian Epithelial Cancer | Stage IIIB Ovarian Epithelial Cancer | Stage IIIC Ovarian Epithelial Cancer | Stage IIIA Primary... and other conditions

United States
OxThera

Terminated

An Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria (ePHex-OLE)

Hyperoxaluria, Primary

United Kingdom, Spain, Belgium, United States, Germany, Tunisia
Brigham and Women's Hospital

Completed

Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism

Primary Hyperparathyroidism

United States
M.D. Anderson Cancer Center

Unknown

Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism

Primary Hyperparathyroidism

United States
University of Pennsylvania

Completed

EC17 for Intraoperative Imaging for Parathyroidectomy

Primary Hyperparathyroidism

United States
University of Louisville
Norton Healthcare; Jewish Hospital and St. Mary's Healthcare

Completed

Minimally Invasive Radioguided Parathyroidectomy (MIRP)

Primary Hyperparathyroidism

United States
Columbia University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Primary Hyperparathyroidism: Non-classical Manifestations

Primary Hyperparathyroidism

United States
St. Jude Children's Research Hospital

Recruiting

An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks

Childhood Cancer | Cardiomyopathy, Primary

United States
Matthew J. Frigault, M.D.
Novartis

Active, not recruiting

Tisagenlecleucel In Primary CNS Lymphoma

Primary CNS Lymphoma | Refractory Primary CNS Lymphoma | Relapsed Primary CNS Lymphoma

United States
VR1 Corporation

Terminated

A Prospective Observational Registry of Primary Headache Patients Treated With Ausanil

Primary Headache Disorders

United States
National Cancer Institute (NCI)

Completed

Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations

Advanced Breast Cancer | Advanced Solid Tumors | Primary Peritoneal Cancer | Advanced Ovarian Cancer

United States
Qlaris Bio, Inc.

Recruiting

Qlaris Phase 2 Study of QLS-111 in POAG and/or OHT Patients

Primary Open Angle Glaucoma of Both Eyes | Primary Open Angle Glaucoma (POAG) | Primary Open-Angle Glaucoma, Unspecified Eye | Ocular Hypertension (OHT)

United States
University of Cincinnati

Active, not recruiting

Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

Liver Metastases | Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer

United States
University of Arizona

Unknown

IMPACT - Integrative Medicine PrimAry Care Trial (IMPACT)

Adult Primary Care Patients

United States
Rush University Medical Center

Completed

Parent Training in Pediatric Care: A Self Directed Tablet-Based Approach

Primary Care | Parent Training

United States
Ohio State University Comprehensive Cancer Center

Completed

Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
National Cancer Institute (NCI)

Completed

Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States
The Cleveland Clinic

Enrolling by invitation

Migraine Medication Effects on Urinary Symptoms

Overactive Bladder | Migraine | Migraine Disorders | Overactive Detrusor | Interstitial Cystitis | Overactive Bladder Syndrome | Bladder Pain Syndrome

United States
Washington University School of Medicine
Columbia University

Completed

Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma

Ovarian Carcinoma | Primary Peritoneal Carcinoma

United States
Mayo Clinic
National Institutes of Health (NIH); Oxalosis and Hyperoxaluria Foundation...

Withdrawn

International Registry for Primary Hyperoxaluria

Kidney Stones | Nephrocalcinosis | Primary Hyperoxaluria

United States
University of Washington
National Cancer Institute (NCI)

Terminated

Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States

Clinical Trials on Primary Molar Pulpotomy in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations